COVID-19

News

Enanta lawsuit claims Pfizer's Paxlovid infringes its patent

US biotech Enanta Pharma has filed a lawsuit against Pfizer, claiming that its oral antiviral for COVID-19 Paxlovid infringes one of its patents and seeking damages from the pharma giant.

News

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

Moderna says COVID booster works against Omicron subvariants

Moderna has reported top-line data suggesting that its COVID-19 booster vaccine candidate stimulates a strong immune response against the Omicron subvariants BA.4 and BA.5, which have drive

Partner Content

Partner Content

Understanding the True Impact of the COVID-19 Pandemic on th...

Complexities demonstrate the need for more resources

Market Access

IP is no barrier to COVID vaccine access, says industry

While proponents argue waiving IP on COVID-19 vaccines would better enable low- and middle-income countries to inoculate their populations, the pharma industry has called the proposals “unn

Market Access

Six months after authorization, what do we know about Paxlov...

It has now been over six months since the

News

FDA advisors back COVID jabs for very young children

The FDA's vaccines advisors have voted in favour of extending the use of mRNA-based COVID-19 vaccine from Moderna and Pfizer/BioNTech to include children from the ages of six months.

Enanta lawsuit claims Pfizer's Paxlovid infringes its patent

Moderna says COVID booster works against Omicron subvariants

Understanding the True Impact of the COVID-19 Pandemic on th...

IP is no barrier to COVID vaccine access, says industry

Six months after authorization, what do we know about Paxlov...

FDA advisors back COVID jabs for very young children

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks